Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background: Starting from 2019, the government has been aiming to increase the immunization coverage by up to 93%. Community pharmacists are well-positioned to extend access to immunizations by providing immunization services to patients. This objective of this study was to determine community pharmacists' attitudes and knowledge on providing immunizations including perceived barriers to immunizing. Methods: This study was a cross-sectional survey conducted in the community pharmacies in Yogyakarta province, between August to October 2019. A pre-validated questionnaire was used and piloted to a small group of pharmaciets. A convenience sampling was chosen and written informed consent was required. The questionnaire included demographic characteristics of participating pharmacists’, their readiness to provide immunization, and the barriers that may potentially happen when community pharmacists’ implement immunization services. Descriptive statistics were used to present the received data. Result: Among 120 respondents, mostly female (80.83%) and pharmacists degree as education (81.67%). Additionally, to the easiness of accessibility, community pharmacists believed that they will have a powerful role in increasing the rate of immunization and improving the vaccination service. More than half of respondents (54.17%) did not fully have good knowledge of all aspect of vaccine administration. Several barriers have been identified as the factors that can contribute to the immunization services by pharmacists. The largest barrier is the lack of regulation governing immunization by pharmacists (95.83%). Followed by a lack of competency (70.83%), lack of skills training (66.67%), lack of equipment (63.3%), and high workload on conventional services (54.17%). Conclusion: Community pharmacists have a good perception of providing immunization services but the lack of regulation, competency, and skills training becomes a barrier in providing immunization services.
Background: Starting from 2019, the government has been aiming to increase the immunization coverage by up to 93%. Community pharmacists are well-positioned to extend access to immunizations by providing immunization services to patients. This objective of this study was to determine community pharmacists' attitudes and knowledge on providing immunizations including perceived barriers to immunizing. Methods: This study was a cross-sectional survey conducted in the community pharmacies in Yogyakarta province, between August to October 2019. A pre-validated questionnaire was used and piloted to a small group of pharmaciets. A convenience sampling was chosen and written informed consent was required. The questionnaire included demographic characteristics of participating pharmacists’, their readiness to provide immunization, and the barriers that may potentially happen when community pharmacists’ implement immunization services. Descriptive statistics were used to present the received data. Result: Among 120 respondents, mostly female (80.83%) and pharmacists degree as education (81.67%). Additionally, to the easiness of accessibility, community pharmacists believed that they will have a powerful role in increasing the rate of immunization and improving the vaccination service. More than half of respondents (54.17%) did not fully have good knowledge of all aspect of vaccine administration. Several barriers have been identified as the factors that can contribute to the immunization services by pharmacists. The largest barrier is the lack of regulation governing immunization by pharmacists (95.83%). Followed by a lack of competency (70.83%), lack of skills training (66.67%), lack of equipment (63.3%), and high workload on conventional services (54.17%). Conclusion: Community pharmacists have a good perception of providing immunization services but the lack of regulation, competency, and skills training becomes a barrier in providing immunization services.
Background: AstraZeneca is the viral vector vaccine. This vaccine has a more advanced method that uses a modified virus to trigger antibodies to fight the Covid-19 virus. Objective: To evaluate the impact of Body Mass Index on the Antibody Titer after AstraZeneca Vaccination atUTA'45 Vaccine Center. Method: Cross-sectional prospective method was used in this study with a convenience sampling design. Only participants who signed the informed consent were included in this study. Results: The results of the P-value on the comparison of Gender and BMI are 0.36 which indicates a correlation between BMI and Gender, also in BMI and age (the P-Value of the comparison of age and BMI was 0.57) BMI plays an important role in the comparison of these factors. BMI is one of the factors that influence the development of antibodies after vaccination. Antibody titer 2 is significantly affected by BMI, the correlation between BMI and antibody titer 2 is very significant ( P-Value 0,000). Conclusion: Based on this study, it was found that there was a correlation between Age, Gender, and BMI on Antibody Titer after AstraZeneca vaccination. However, the correlation between Age and Gender to BMI is not very significant, the presence of factors can still affect Antibody Titers. In addition, it can also be concluded that there is a very significant correlation between antibody titer 2 (post-vaccination antibody titer) and a person's BMI. This is shown from the results of the P-Value of 0.000.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.